M
Miquel Navasa
Researcher at University of Barcelona
Publications - 185
Citations - 16466
Miquel Navasa is an academic researcher from University of Barcelona. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 60, co-authored 181 publications receiving 15473 citations. Previous affiliations of Miquel Navasa include University of Bern & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
Pau Sort,Miquel Navasa,Vicente Arroyo,Xavier Aldeguer,Ramon Planas,Luis Ruiz-del-Arbol,Lluis Castells,Victor Vargas,Germán Soriano,Mónica Guevara,Pere Ginès,Joan Rodés +11 more
TL;DR: In patients with cirrhosis and spontaneous bacterial peritonitis, treatment with intravenous albumin in addition to an antibiotic reduces the incidence of renal impairment and death in comparison with treatment with an antibiotic alone.
Journal ArticleDOI
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Antoni Rimola,Guadalupe Garcia-Tsao,Miquel Navasa,Laura J. V. Piddock,Ramon Planas,B Bernard,John M. Inadomi +6 more
TL;DR: This article represents the final consensus document and is divided into three separate sections concerning the diagnosis, treatment and prophylaxis of SBI?
Journal ArticleDOI
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Angels Ginès,Angels Escorsell,Pere Ginès,Joan Saló,Wladimiro Jiménez,Luis Inglada,Miquel Navasa,Joan Clària,Antoni Rimola,Vicente Arroyo,Joan Rodés +10 more
TL;DR: The hepatorenal syndrome is a relatively frequent complication in cirrhotic patients with ascites that is associated with an extremely short survival and Liver size, plasma renin activity, and serum sodium concentration are predictors of hepatorenAL syndrome occurrence in these patients.
Journal ArticleDOI
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Javier Fernández,Miquel Navasa,Ramon Planas,Silvia Montoliu,David Monfort,Germán Soriano,Carmen Vila,Alberto Pardo,Enrique Quintero,Victor Vargas,José Such,Pere Ginès,Vicente Arroyo +12 more
TL;DR: In this paper, the authors showed that primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis, reducing the incidence of spontaneous bacterial peritonitis, delaying the development of hepatorenal syndrome, and improving survival.
Journal ArticleDOI
Hepatitis C virus kinetics during and immediately after liver transplantation.
Montserrat García-Retortillo,Xavier Forns,Anna Feliu,Eduardo Moitinho,Josep Costa,Miquel Navasa,Antoni Rimola,Juan Rodés +7 more
TL;DR: A sharp decrease in HCV viral load occurs during the anhepatic phase and immediately after graft reperfusion, most likely owing to a lack of virion production and hepatic viral clearance.